Stay updated on Apremilast in Nummular Eczema Clinical Trial
Sign up to get notified when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.

Latest updates to the Apremilast in Nummular Eczema Clinical Trial page
- CheckyesterdayChange DetectedThe site revision in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a 403 Forbidden error page with the site header and footer, indicating access is blocked rather than showing the study details.SummaryDifference19%

- Check44 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, representing a small update to the study record metadata rather than substantive changes to the study details.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, with no visible changes to the study details or page structure.SummaryDifference0.1%

- Check79 days agoChange DetectedA new Publications entry citing Bohner A. et al. about the apremilast/nummular eczema study is added, with a PubMed note; the page revision is updated to v3.6.4, replacing the prior v3.6.3 entry.SummaryDifference0.3%

- Check101 days agoChange DetectedA new revision tag (v3.6.3) has been added, replacing the previous revision (v3.6.2). This indicates a minor update to the page without changing the study information.SummaryDifference0.1%

Stay in the know with updates to Apremilast in Nummular Eczema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.